JPMorgan Chase & Co. Cuts Billiontoone (NASDAQ:BLLN) Price Target to $130.00

Billiontoone (NASDAQ:BLLN) had its price objective cut by JPMorgan Chase & Co. from $145.00 to $130.00 in a research note issued to investors on Thursday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other equities analysts have also weighed in on the stock. BTIG Research reduced their target price on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a report on Thursday. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Finally, Guggenheim assumed coverage on Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 price objective on the stock. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and an average target price of $126.71.

Billiontoone Trading Up 1.9%

NASDAQ BLLN opened at $93.39 on Thursday. Billiontoone has a one year low of $61.96 and a one year high of $150.44. The company’s 50 day moving average price is $116.49 and its 200 day moving average price is $94.28. The company has a debt-to-equity ratio of 0.17, a quick ratio of 10.58 and a current ratio of 11.69. The firm has a market capitalization of $4.30 billion and a price-to-earnings ratio of 133.41.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million for the quarter. On average, sell-side analysts predict that Billiontoone will post 0.92 EPS for the current year.

Insiders Place Their Bets

In other Billiontoone news, insider Shan Riku Sakakibara sold 8,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $110.00, for a total transaction of $880,000.00. Following the completion of the sale, the insider owned 208,000 shares in the company, valued at $22,880,000. This trade represents a 3.70% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 32,500 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total value of $4,450,875.00. Following the completion of the transaction, the chief executive officer directly owned 20,000 shares in the company, valued at approximately $2,739,000. The trade was a 61.90% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 202,049 shares of company stock worth $23,496,861. Company insiders own 50.22% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Baillie Gifford & Co. acquired a new stake in shares of Billiontoone in the 4th quarter valued at about $103,786,000. Emerald Mutual Fund Advisers Trust grew its stake in Billiontoone by 11.9% in the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after purchasing an additional 14,072 shares in the last quarter. Perceptive Advisors LLC increased its holdings in Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock valued at $7,248,000 after buying an additional 19,000 shares during the last quarter. Massachusetts Financial Services Co. MA bought a new stake in Billiontoone in the fourth quarter valued at about $13,373,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in Billiontoone during the first quarter valued at approximately $1,539,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.